Lytvyn Y, Godoy LC, Scholtes RA, van Raalte DH, Cherney DZ (2019) Mineralocorticoid antagonism and diabetic kidney disease
the precise BMI cutoffs for children differ by age
Preliminary studies suggest that GLP-1 receptor agonists may offer benefits in neurological conditions like Alzheimers disease, substance use disorders, polycystic ovary syndrome (PCOS), and even non-alcoholic steatohepatitis (NASH)
GLP-1 Medications and Gastroparesis: Understanding a Serious Side Effect Category: Southwest General Medical Group, Women's Health, Gastroenterology, General Health, Family Medicine, Endocrinology, Diabetes & Metabolism, Men's Health, Diet Posted On: GLP-1 medications, such as Ozempic and Wegovy, have helped many people manage type 2 diabetes and achieve significant weight loss
The cardiovascular benefits, including reductions in MACE and stroke, also accumulate over time, with the most substantial gains observed within the first 24 to 36 months of treatment [124, 125]
Its roles in immune function, protein synthesis, and cellular metabolism are well-established in nutritional science